科研成果详情

题名Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma
作者
发表日期2016-12-31
发表期刊INTERNATIONAL JOURNAL OF NANOMEDICINE   影响因子和分区
语种英语
原始文献类型Article
关键词multidrug resistance P-glycoprotein micelle doxorubicin zebrafish
其他关键词OVERCOME MULTIDRUG-RESISTANCE ; PLURONIC BLOCK-COPOLYMERS ; P-GLYCOPROTEIN EXPRESSION ; BETA-CYCLODEXTRIN ; CANCER-CELLS ; DOXORUBICIN DELIVERY ; ANTITUMOR EFFICACY ; POLYMERIC MICELLES ; ENERGY DEPLETION ; DOWN-REGULATION
摘要P-glycoprotein (P-gp) overexpression has become the most common cause of occurrence of multidrug resistance in clinical settings. We aimed to construct a micellar polymer carrier to sensitize drug-resistant tumors to doxorubicin (DOX). This A-B-C-type amphiphilic copolymer was prepared by the sequential linkage of beta-cyclodextrin, hydrophobic poly(D, L-lactide), and hydrophilic poly(ethylene glycol). Upon incubation of the DOX-loaded micelles with DOX-resistant human breast carcinoma MCF-7/ADR cells, significantly enhanced cytotoxicity and apoptosis were achieved. A series of studies on the action mechanism showed that the polymer components such as beta-cyclodextrin, hydrophobic poly(D, L-lactide) segment, and poly(ethylene glycol) coordinatively contributed to the improved intracellular ATP depletion and ATPase activity, increased intracellular uptake of P-gp substrates via competitive binding to P-gp, and decreased P-gp expression in MCF-7/ADR cells. More interestingly, a similar phenomenon was observed in the zebrafish xenograft model, resulting in similar to 64% inhibition of MCF-7/ADR tumor growth. These results implied that the polymeric micelles displayed great potentials as P-gp modulators to reverse DOX resistance in MCF-7/ADR breast carcinoma.
资助项目National Natural Science Funds for Excellent Young Scholar [81222047]; National Natural Science FundsNational Natural Science Foundation of China (NSFC) [81473173]
出版者DOVE MEDICAL PRESS LTD
出版地ALBANY
ISSN1178-2013
EISSN1178-2013
卷号11页码:5205-5220
DOI10.2147/IJN.S115956
页数16
WOS类目Nanoscience & Nanotechnology ; Pharmacology & Pharmacy
WOS研究方向Science & Technology - Other Topics ; Pharmacology & Pharmacy
WOS记录号WOS:000385046600001
收录类别SCIE ; PUBMED ; SCOPUS
URL查看原文
PubMed ID27785023
PMC记录号PMC5066852
SCOPUSEID2-s2.0-84991577868
通讯作者地址[Qiu, Liyan]Ministry of Education (MOE),Key Laboratory of Macromolecular Synthesis and Functionalization,Department of Polymer Science and Engineering,Zhejiang University,38 Zheda Road,Hangzhou,310027,China
Scopus学科分类Biophysics;Bioengineering;Biomaterials;Pharmaceutical Science;Drug Discovery;Organic Chemistry
引用统计
被引频次:6[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符https://kms.wmu.edu.cn/handle/3ETUA0LF/4290
专题附属第一医院_药物临床试验机构办公室
通讯作者Qiu, Liyan
作者单位
1.Ministry of Education (MOE),Key Laboratory of Macromolecular Synthesis and Functionalization,Department of Polymer Science and Engineering,Zhejiang University,Hangzhou,China;
2.Drug Clinical Trial Office,The First Affiliated Hospital of Wenzhou Medical University,Wenzhou,China;
3.College of Pharmaceutical Sciences,Zhejiang University,Hangzhou,China
第一作者单位附属第一医院;  第一临床医学院(信息与工程学院)、附属第一医院
推荐引用方式
GB/T 7714
Zhang, Lu,Lu, Jiafei,Qiu, Liyan. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma[J]. INTERNATIONAL JOURNAL OF NANOMEDICINE,2016,11:5205-5220.
APA Zhang, Lu, Lu, Jiafei, & Qiu, Liyan. (2016). Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma. INTERNATIONAL JOURNAL OF NANOMEDICINE, 11, 5205-5220.
MLA Zhang, Lu,et al."Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma".INTERNATIONAL JOURNAL OF NANOMEDICINE 11(2016):5205-5220.

条目包含的文件

条目无相关文件。
个性服务
查看访问统计
谷歌学术
谷歌学术中相似的文章
[Zhang, Lu]的文章
[Lu, Jiafei]的文章
[Qiu, Liyan]的文章
百度学术
百度学术中相似的文章
[Zhang, Lu]的文章
[Lu, Jiafei]的文章
[Qiu, Liyan]的文章
必应学术
必应学术中相似的文章
[Zhang, Lu]的文章
[Lu, Jiafei]的文章
[Qiu, Liyan]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。